Evidence map›Paper›PMID 25232064›Full record

SynthesisBMJ (Clinical research ed.)2014

Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis.

Neha Pathak, Julie Dodds, Javier Zamora, Khalid Khan

4 registry-linked trialsAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMJ (Clinical research ed.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 99 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04920526 unknown statusnot on this mapstarted 2021, after this paper: background citation

Effectiveness of the QHPV Among Kenyan HIV Infected Girls and Boys 9 Years Post Vaccination

TypeobservationalSponsorKenya Medical Research InstituteRan2021 to 2022Enrolled135ConditionsHPV-Related CarcinomaArmsQuadrivalent HPV [Type 6, 11, 16 and 18] L1 Virus-Like Particle Vaccine
NCT05210348 unknown statusnot on this mapstarted 2021, after this paper: background citation

Clinical Evaluation Study of Urine hrHPV Detection for the Diagnosis of Presence of Cervical HPV and Correlation of Cervical Lesions

TypeobservationalSponsorPeking University People's HospitalRan2021 to 2022Enrolled1,000ConditionsHuman Papillomavirus Infection, Cervical Cancer, Human Papilloma Virus, Negative for Intraepithelial Lesion or Malignancy
NCT05236855 unknown statusnot on this mapstarted 2022, after this paper: background citation

Spectroscopy and Artificial Intelligence to Disrupt the Status Quo in Cervical Cancer

TypeobservationalSponsorIWK Health CentreRan2022 to 2022Enrolled200ConditionsCervical Cancer, HPVArmsSpectoscropy testing of urine specimen
NCT05613283 active not recruitingnot on this mapstarted 2022, after this paper: background citation

Primary Cervical Cancer Screening by Self-sampling HPV Test

TypeobservationalSponsorPeking University People's HospitalRan2022 to 2027Enrolled17,875ConditionsHuman Papillomavirus Infection, Cervical Cancer, Negative For Intraepithelial Lesion Or Malignancy, Atypical Squamous Cells of Undetermined Significance
3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. A Randomized Comparison of Different Vaginal Self-sampling Devices and Urine for Human Papillomavirus Testing-Predictors 5.1.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2021
    Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Towards Global HPV Eradication: Single-Dose HPV Vaccination vs. Pseudoscience.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Observational
  19. Article
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Neha PathakWomen's Health Research Unit, Centre for Primary Care and Public Health, Blizard Institute, Barts and The London School of Medicine and dentistry, London E1 2AB, UK.
Julie DoddsWomen's Health Research Unit, Centre for Primary Care and Public Health, Blizard Institute, Barts and The London School of Medicine and dentistry, London E1 2AB, UK.
Javier ZamoraWomen's Health Research Unit, Centre for Primary Care and Public Health, Blizard Institute, Barts and The London School of Medicine and dentistry, London E1 2AB, UK Clinical Biostatistics Unit, Hospital Ramon y Cajal (IRYCIS) and CIBER Epidemiologia y Salud Publica, Madrid, Spain javier.zamora@hrc.es.
Khalid KhanWomen's Health Research Unit, Centre for Primary Care and Public Health, Blizard Institute, Barts and The London School of Medicine and dentistry, London E1 2AB, UK.

Funding

Medical Research Council G0901608
6 · The paper itself

Abstract

objectiveTo determine the accuracy of testing for human papillomavirus (HPV) DNA in urine in detecting cervical HPV in sexually active women.

designSystematic review and meta-analysis. DATA SOURCES: Searches of electronic databases from inception until December 2013, checks of reference lists, manual searches of recent issues of relevant journals, and contact with experts. ELIGIBILITY CRITERIA: Test accuracy studies in sexually active women that compared detection of urine HPV DNA with detection of cervical HPV DNA. DATA EXTRACTION AND SYNTHESIS: Data relating to patient characteristics, study context, risk of bias, and test accuracy. 2 × 2 tables were constructed and synthesised by bivariate mixed effects meta-analysis.

results16 articles reporting on 14 studies (1443 women) were eligible for meta-analysis. Most used commercial polymerase chain reaction methods on first void urine samples. Urine detection of any HPV had a pooled sensitivity of 87% (95% confidence interval 78% to 92%) and specificity of 94% (95% confidence interval 82% to 98%). Urine detection of high risk HPV had a pooled sensitivity of 77% (68% to 84%) and specificity of 88% (58% to 97%). Urine detection of HPV 16 and 18 had a pooled sensitivity of 73% (56% to 86%) and specificity of 98% (91% to 100%). Metaregression revealed an increase in sensitivity when urine samples were collected as first void compared with random or midstream (P=0.004). LIMITATIONS: The major limitations of this review are the lack of a strictly uniform method for the detection of HPV in urine and the variation in accuracy between individual studies.

conclusionsTesting urine for HPV seems to have good accuracy for the detection of cervical HPV, and testing first void urine samples is more accurate than random or midstream sampling. When cervical HPV detection is considered difficult in particular subgroups, urine testing should be regarded as an acceptable alternative.

Indexed as

Human Papillomavirus DNA TestsAlphapapillomavirusCervix UteriDNA, ViralFemaleHumansPapillomavirus InfectionsSensitivity and SpecificityUrinalysisUrine Specimen CollectionDNA, Viral

Identifiers

PMID25232064
PMCPMC4166201

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.